Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer

Ertan E., OĞUZ SOYDİNÇ H., YAZAR A., Ustuner Z., TAŞ F., Yasasever V.

TUMORI, vol.97, no.3, pp.286-289, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 97 Issue: 3
  • Publication Date: 2011
  • Doi Number: 10.1700/912.10023
  • Journal Name: TUMORI
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.286-289
  • Keywords: chemotherapy, matrix metalloproteinase-9, non-small cell lung cancer, ENDOTHELIAL GROWTH-FACTOR, SERUM-LEVELS, EXPRESSION, MMP-9, ADENOCARCINOMA, PROGNOSIS, SURVIVAL
  • Acibadem Mehmet Ali Aydinlar University Affiliated: Yes


Aims and background. The aim of the study was to investigate the alteration in serum matrix metalloproteinase-9 (MMP-9) levels after chemotherapy and the association between the changes in serum levels of MMP-9 and response to chemotherapy in patients with advanced stage non-small cell lung cancer.